Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivastigmine Bitartrate Oral Solution

Approval Number

国药准字H20244630

Company呋欧医药科技（湖州）有限公司

Registration Date

August 5, 2024

Drug Information

Generic Name

重酒石酸利斯的明口服溶液

Dosage Form

口服溶液剂

Strength

50ml：0.1g（按C₁₄H₂₂N₂O₂计）

Drug Type

化学药品

Registration Date

August 5, 2024

Company Information

Applicant Company

Company Name呋欧医药科技（湖州）有限公司

Company Address

浙江省湖州市湖州经济技术开发区龙溪街道王母山路1800号1号楼二层207

Manufacturing Company

Company Name浙江凯润药业股份有限公司

Company Address

浙江省湖州市德清县阜溪街道英溪北路689号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy